TriSalus Life Sciences (TLSI) EBIT Margin (QoQ) (2022 - 2026)
TriSalus Life Sciences (TLSI) EBIT Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.83 Bn | 197.23 Bn | 7.27 Bn |
| 2 | Stryker | 126.24 Bn | 122.76 Bn | 4.50 Bn |
| 3 | Medtronic | 119.38 Bn | 110.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.76 Bn | 47.51 Bn | 1.35 Bn |
| 6 | Dexcom | 35.12 Bn | 33.17 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.77 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn |
| 10 | TriSalus Life Sciences | 308.97 Mn | 262.68 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 849.00 |
| Mar 31, 2026 | -6,975.00 |
| Dec 31, 2025 | 5,316.00 |
| Sep 30, 2025 | -1,255.00 |
| Jun 30, 2025 | 1,456.00 |
| Mar 31, 2025 | 1,181.00 |
| Dec 31, 2024 | 2,716.00 |
| Sep 30, 2024 | -791.00 |
| Jun 30, 2024 | 6,977.00 |
| Mar 31, 2024 | 6,828.00 |
| Dec 31, 2023 | 10,944.00 |
| Sep 30, 2023 | -11,056.00 |
| Jun 30, 2023 | 9,126.00 |
| Mar 31, 2023 | 2,573.00 |
| Dec 31, 2022 | -15,816.00 |